Skip to main content

Advertisement

SpringerLink
Log in

Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

When we classified neovascular exudative age-related macular degeneration (AMD) into three types of polypoidal choroidal vasculopathy (PCV), typical AMD, and retinal angiomatous proliferation (RAP) in our previous study, we reported 5.5% had the combined cases, such as one eye had PCV and the other eye had typical AMD. We examined the clinical characteristics of these combined cases in the current study.

Methods

All cases underwent fluorescein and indocyanine green angiography (FA and ICGA) at the initial examination. All PCV cases were diagnosed definitively based on characteristic aneurysmal lesions seen on ICGA. Follow-up examinations also were conducted to determine whether polypoidal lesions had developed in the eyes with typical AMD.

Results

Among 349 patients with neovascular AMD, 20 (5.7%) had one eye with PCV and the other eye with typical AMD. The average age was 73 years. The mean best-corrected visual acuity levels at the initial examination in eyes with PCV and typical AMD were 0.20 and 0.43, respectively (p = 0.09). All subgroups of classic and occult CNV were observed in the eyes with typical AMD on FA. During the follow-up period (average, 21.7 months), PCV developed in ten eyes with typical AMD at the initial examination.

Conclusions

Although some cases might include different stages of progression or probable cases of PCV, the combined cases in which one eye has PCV and the other eye has typical AMD suggest that those clinical entities are not independent and possibly overlap.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ali F, Chan WC, Stevenson MR, Muldrew KA, Chakravarthy U (2004) Morphometric analysis of angiograms of exudative lesions in age-related macular degeneration. Arch Ophthalmol 122:710–715. doi:10.1001/archopht.122.5.710

    Article  PubMed  Google Scholar 

  2. Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group (2003) Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Arch Ophthalmol 121:1253–1268. doi:10.1001/archopht.121.9.1253

    Article  CAS  PubMed  Google Scholar 

  3. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314:989–992. doi:10.1126/science.1133807

    Article  CAS  PubMed  Google Scholar 

  4. Gotoh N, Nakanishi H, Hayashi H, Yamada R, Otani A, Tsujikawa A, Yamashiro K, Tamura H, Saito M, Saito K, Iida T, Matsuda F, Yoshimura N (2009) ARMS2 (LOC387715) Variants in Japanese Patients with Exudative Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Am J Ophthalmol 147:1037–1041. doi:10.1016/j.ajo.2008.12.036

    Article  CAS  PubMed  Google Scholar 

  5. Gotoh N, Yamada R, Nakanishi H, Saito M, Iida T, Matsuda F, Yoshimura N (2008) Correlation between CFH Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Exper Ophthalmol 36:437–442. doi:10.1111/j.1442-9071.2008.01791.x

    Google Scholar 

  6. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan SJ (1986) Formation of drusen in the human eye. Am J Ophthalmol 101:342–353

    CAS  PubMed  Google Scholar 

  7. Japanese Study Group of Polypoidal Choroidal Vasculopathy (2005) Criteria for diagnosis of polypoidal choroidal vasculopathy (in Japanese). Nippon Gannka Gakkai Zasshi 109:417–427

    Google Scholar 

  8. Klein R, Klein BE, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104:7–21

    CAS  PubMed  Google Scholar 

  9. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 109:1767–1779. doi:10.1016/S0161-6420(02)01146-6

    Article  PubMed  Google Scholar 

  10. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A (2007) LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 144:608–612. doi:10.1016/j.ajo.2007.06.003

    Article  CAS  PubMed  Google Scholar 

  11. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A (2008) Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 49:1101–1105. doi:10.1167/iovs.07-1145

    Article  PubMed  Google Scholar 

  12. Ladas ID, Karagiannis DA, Georgalas I, Rouvas AA, Moschos MM, Apostolopoulos M (2004) Polypoidal choroidal vasculopathy associated with Doyne's familial choroiditis: treatment with thermal laser. Eur J Ophthalmol 14:264–268

    CAS  PubMed  Google Scholar 

  13. Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15–22. doi:10.1016/j.ajo.2007.03.047

    Article  PubMed  Google Scholar 

  14. Mitchell P, Wang JJ, Foran S, Smith W (2002) Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109:1092–1097. Erratum in: Ophthalmology (2002) 109:1588. doi:10.1016/S0161-6420(02)01055-2

    Article  PubMed  Google Scholar 

  15. Miyazaki M, Kiyohara Y, Yoshida A, Iida M, Nose Y, Ishibashi T (2005) The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 46:1907–1910. doi:10.1167/iovs.04-0923

    Article  PubMed  Google Scholar 

  16. Mori K, Horie-Inoue K, Kohda M, Kawasaki I, Gehlbach PL, Awata T, Yoneya S, Okazaki Y, Inoue S (2007) Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J Hum Genet 52:636–641. doi:10.1007/s10038-007-0162-1

    Article  CAS  PubMed  Google Scholar 

  17. Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T (2001) Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85:1153–1157. doi:10.1136/bjo.85.10.1153

    Article  CAS  PubMed  Google Scholar 

  18. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials–TAP report. Arch Ophthalmol 117:1329–1345

    Google Scholar 

  19. Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–648. doi:10.1016/S0002-9394(02)01404-6

    Article  PubMed  Google Scholar 

  20. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102:205–210

    CAS  PubMed  Google Scholar 

  21. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314:992–993. doi:10.1126/science.1133811

    Article  CAS  PubMed  Google Scholar 

  22. Yoshida T, DeWan A, Zhang H, Sakamoto R, Okamoto H, Minami M, Obazawa M, Mizota A, Tanaka M, Saito Y, Takagi I, Hoh J, Iwata T (2007) HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 13:545–548

    CAS  PubMed  Google Scholar 

Download references

Funding

None.

Competing interests

None.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1247, Japan

    Ichiro Maruko, Tomohiro Iida, Masaaki Saito & Dai Nagayama

Authors
  1. Ichiro Maruko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomohiro Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaaki Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dai Nagayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ichiro Maruko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruko, I., Iida, T., Saito, M. et al. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 248, 361–368 (2010). https://doi.org/10.1007/s00417-009-1276-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1276-2

Keywords

Search

Navigation